Aarti Drugs Announces Key Leadership Transition and Management Changes
Aarti Drugs Ltd 路 Change in Management 路 01 Oct 2026, 1:20 am
Aarti Drugs Announces Key Leadership Transition and Management Changes Aarti Drugs Limited announced the early retirement of Prakash M. Patil, who stepped down as Chairman, Managing Director, and CEO effective from the close of business hours on 30th Sep'26. Following shareholder approval at the AGM on 26th Sep'26, Adhish P. Patil has been promoted to Managing Director effective 1st Oct'26, consequently relinquishing his position as Chief Financial Officer on 30th Sep'26 while continuing CFO oversight until a new appointment is finalized.
Original exchange filing (PDF)
More announcements from Aarti Drugs Ltd
- Intimation of sad demise of Promoter and Chairman Emeritus of the Company 路 16 Nov 2026
- Transcript of Q2&H1 FY27 Earning Conference call 路 11 Nov 2026
- Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requireents) Regulations, 2015 路 06 Nov 2026
- Audio recording for conference call for Analyst and Investors 路 05 Nov 2026
- Investor Presentation for Q2 FY27 路 04 Nov 2026
- Press release on Financial results for Quarter and Half year ended September 2026 路 04 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 路 04 Nov 2026
- Aarti Drugs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 04 Nov 2026
